Yeh WS - Search Results

1

Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs.

Chen SY, Choi CB, Li Q, Yeh WS, Lee YC, Kao AH, Liang MH. Chen SY, et al. Among authors: yeh ws. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1086-94. doi: 10.1002/acr.22574. Arthritis Care Res (Hoboken). 2015. PMID: 25732795 Free article.

2

Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.

Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G. Collard HR, et al. Among authors: yeh ws. Ann Am Thorac Soc. 2015 Jul;12(7):981-7. doi: 10.1513/AnnalsATS.201412-553OC. Ann Am Thorac Soc. 2015. PMID: 25923447

3

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Raghu G, et al. Among authors: yeh ws. Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27. Lancet Respir Med. 2014. PMID: 24875841

4

An Analysis of Us Medicare Beneficiaries: Burden of Direct Medical Costs in Patients With Idiopathic Pulmonary Fibrosis.

Chen SY, Collard HR, Yeh WS, Li Q, Lee YC, Wang A, Raghu G. Chen SY, et al. Among authors: yeh ws. Value Health. 2014 Nov;17(7):A592. doi: 10.1016/j.jval.2014.08.2034. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202026 Free article. No abstract available.

5

Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.

Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR. Raghu G, et al. Among authors: yeh ws. Eur Respir J. 2016 Jul;48(1):179-86. doi: 10.1183/13993003.01653-2015. Epub 2016 Apr 28. Eur Respir J. 2016. PMID: 27126689 Free article.

6

The economic burden of spinal muscular atrophy.

Armstrong EP, Malone DC, Yeh WS, Dahl GJ, Lee RL, Sicignano N. Armstrong EP, et al. Among authors: yeh ws. J Med Econ. 2016 Aug;19(8):822-6. doi: 10.1080/13696998.2016.1198355. Epub 2016 Jun 13. J Med Econ. 2016. PMID: 27264163 Free article.

7

Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer.

Burudpakdee C, Wong W, Seetasith A, Corvino FA, Yeh W, Gubens M. Burudpakdee C, et al. Lung Cancer. 2018 May;119:103-111. doi: 10.1016/j.lungcan.2018.03.008. Epub 2018 Mar 9. Lung Cancer. 2018. PMID: 29656744 Free article. Clinical Trial.

8

Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data.

Nicholas J, Boster A, Wu N, Yeh WS, Fay M, Kendter J, Huang MY, Lee A. Nicholas J, et al. Among authors: yeh ws. Pharmacoecon Open. 2018 Mar;2(1):31-41. doi: 10.1007/s41669-017-0035-2. Pharmacoecon Open. 2018. PMID: 29464673 Free PMC article.

9

Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.

Yeh WS, Armstrong EP, Skrepnek GH, Malone DC. Yeh WS, et al. Pharmacotherapy. 2007 Jun;27(6):813-24. doi: 10.1592/phco.27.6.813. Pharmacotherapy. 2007. PMID: 17542764

10

Analysis of Excess Direct Medical Costs of Vision Impairment in Taiwan.

Wang MT, Ng K, Sheu SJ, Yeh WS, Lo YW, Lee WJ. Wang MT, et al. Among authors: yeh ws. Value Health Reg Issues. 2013 May;2(1):57-63. doi: 10.1016/j.vhri.2013.01.006. Epub 2013 Mar 13. Value Health Reg Issues. 2013. PMID: 29702854 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters